Who

Professor Gavin Giovannoni MBBCh, PhD, FCP (S.A., Neurol.), FRCP, FRCPath

I was appointed to the Chair of Neurology, Blizard Institute, Barts and The London School of Medicine and Dentistry, in September 2008.


I took over as the Neuroscience and Trauma Centre Lead in the Blizard Institute.

I did my undergraduate medical training at the University of the Witwatersrand, South Africa.

I graduated cum laude in 1987 winning the prizes for best graduate in medicine and surgery. After completing my neurology specialist training in in South Africa I moved to the Institute of Neurology, Queen Square, London in 1993.

After three years as a clinical research fellow, under Professor Ed Thompson, and then two years as the Scarfe Lecturer, working for Professor W. Ian McDonald, I was awarded a PhD in immunology from the University of London in 1998.

I was appointed as a Clinical Senior Lecturer, Royal Free and University College Medical School, in 1998.

I moved back to Institute of Neurology, Queen Square in 1999 and was made a Reader in Neuroimmunology in 2004.

My clinical interests are multiple sclerosis and other inflammatory disorders of the central nervous system. I am particularly interested in clinical issues related to optimising MS disease modifying therapies.

My current research is focused on Epstein Barr virus as a possible cause of multiple sclerosis, multiple sclerosis related neurodegeneration, biomarker discovery and immune tolerance strategies.




Wits Medical School, Johannesburg. Note the approaching thunder storm; typical summer afternoon weather on the highveld.



The National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG. I spent a wonderful 13 years of my life working on the square. Some cherished memories and a warm place in my heart for this gargantuan institution.




The Blizard Institute, Barts and The London School of Medicine, Whitechapel, London. My new home. The East End of London is a very special place; those who have worked there and no the place would understand the craic. 


MouseDoctor

The MouseDoctor spent his academic career based at different places of the University of London . He was awarded a BSc (Hons) in Zoology from Bedford College in 1983 and was awarded a PhD from London University in Immunology/Pathology in 1987 for work at the Institute of Basic medical Science on immunological tolerance induction in delayed hypersensitivity of the skin. He then spent six years as the Angela Limerick lecturer, for multiple sclerosis research at the Hunterian Institute, The Royal College of Surgeons of England working on delayed hypersensitivity in the brain, where he developed an active research interest in multiple sclerosis. He took a 5 year Principal Fellowship to the Institute of Ophthalmology , University College London in 1994 and became the first Senior Fellow of the Multiple Sclerosis Society and moved to the Institute of Neurology , University College London in 1999. He became a senior lecturer in 2003 and got a personal chair in 2004 as Professor of Neuroimmunology. He moved to Queen Mary in the autumn of 2006. 


DrK (Klaus Schmierer PhD FRCP)

Multiple sclerosis has been my clinical and research focus from the beginning of my training in neurology at the Charité Hospital (Humboldt University), which followed undergraduate studies in Berlin and Jerusalem.  In 2001 I moved to London to pursue a career in academic neurology, initially as a Research Fellow, and from 2005 as a Wellcome Intermediate Clinical Fellow at the UCL Institute of Neurology, and an Honorary Consultant Neurologist at The National Hospital for Neurology & Neurosurgery, Queen Square. Here, I investigated the histo-pathological correlates of quantitative MRI using standard and high-field MR systems to improve disease monitoring in people with MS. Following appointment in 2009 at Queen Mary, where I am currently a Reader in Clinical Neurology, my clinical-academic work now includes (i) quantifying the pathological substrate of disease deterioration in pwMS using MRI and quantitative histology; (ii) the Barts MS Database; (iii) in vivo MRI studies to improve the early and differential-diagnosis of MS, and (iv) investigator-led and commercial clinical trials.